Correlation Between Arq and Telomir Pharmaceuticals,

Can any of the company-specific risk be diversified away by investing in both Arq and Telomir Pharmaceuticals, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Arq and Telomir Pharmaceuticals, into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Arq Inc and Telomir Pharmaceuticals, Common, you can compare the effects of market volatilities on Arq and Telomir Pharmaceuticals, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Arq with a short position of Telomir Pharmaceuticals,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Arq and Telomir Pharmaceuticals,.

Diversification Opportunities for Arq and Telomir Pharmaceuticals,

-0.18

Correlation Coefficient

Arq  Telomir Pharmaceuticals,

Good diversification

The 3 months correlation between Arq and Telomir is -0.18. Overlapping area represents the amount of risk that can be diversified away by holding Arq Inc and Telomir Pharmaceuticals, Commo in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Telomir Pharmaceuticals, and Arq is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Arq Inc are associated (or correlated) with Telomir Pharmaceuticals,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Telomir Pharmaceuticals, has no effect on the direction of Arq i.e., Arq and Telomir Pharmaceuticals, go up and down completely randomly.

Pair Corralation between Arq and Telomir Pharmaceuticals,

Considering the 90-day investment horizon Arq Inc is expected to generate 0.55 times more return on investment than Telomir Pharmaceuticals,. However, Arq Inc is 1.83 times less risky than Telomir Pharmaceuticals,. It trades about -0.06 of its potential returns per unit of risk. Telomir Pharmaceuticals, Common is currently generating about -0.14 per unit of risk. If you would invest  725.00  in Arq Inc on October 10, 2024 and sell it today you would lose (43.00) from holding Arq Inc or give up 5.93% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Arq Inc  vs.  Telomir Pharmaceuticals, Commo

Arq Inc

Risk-Adjusted Performance

10 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Arq Inc are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Even with relatively inconsistent basic indicators, Arq reported solid returns over the last few months and may actually be approaching a breakup point.

Telomir Pharmaceuticals,

Risk-Adjusted Performance

1 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Telomir Pharmaceuticals, Common are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of very fragile essential indicators, Telomir Pharmaceuticals, may actually be approaching a critical reversion point that can send shares even higher in February 2025.

Pair Trading with Arq and Telomir Pharmaceuticals,

The main advantage of trading using opposite Arq and Telomir Pharmaceuticals, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Arq position performs unexpectedly, Telomir Pharmaceuticals, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Telomir Pharmaceuticals, will offset losses from the drop in Telomir Pharmaceuticals,'s long position.

The idea behind Arq Inc and Telomir Pharmaceuticals, Common pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.